IPK: Structure, Function and Drug Targets (G64768)

Target Name: IPPK

NCBI ID: G64768

IPPK

IPK: Structure, Function and Drug Targets

IPK (IP5 2-kinase) is a protein that plays a crucial role in cellular signaling pathways. It is a key regulator of the phosphatidylinositol (PIPA) metabolic pathway, which underlies many signaling processes within cells. IPK plays an important role in a variety of physiological processes, including cell proliferation, differentiation, and tumor formation. At the same time, IPK is also considered to be the target of many drugs and chemicals, so its application value in drug development and biomarker research has attracted widespread attention. This article will elaborate on the structure, function, mechanism of action and drug targets of IPK.

Structure and function of IPK

IPK is a 26 kDa protein that contains an N-terminal alpha helix, a central beta page, and a C-terminal domain. IPK has two main functions: one is to bind PIPA and participate in the regulation of phosphatidylinositol metabolic pathways; the other is to modify IP5 through phosphorylation. IP5 is a 21kDa protein composed of two subunits, each subunit Contains a hydrophobic 伪-helix and a hydrophilic 尾-sheet.

In the mechanism of action of IPK, after IPK combines with PIPA, it can activate a series of signaling pathways. Phosphorylation modification of IPK can lead to phosphorylation of IP5, thereby activating the ATPase activity of IP5. Phosphorylation of IP5 can increase the concentration of intracellular ATP, thereby promoting the intracellular signaling process. In addition, phosphorylation of IPK can also induce the aggregation of IP5 to form IP5-IPK dimers, thereby activating the ATPase activity of IPK and further promoting the intracellular signaling process.

IPK plays an important role in a variety of physiological processes, including cell proliferation, differentiation, and tumor formation. During cell proliferation, IPK participates in regulating spindle formation and stability during the cell cycle, thereby affecting the progression of cell division. During the differentiation process, IPK participates in regulating intracellular signaling processes, thereby affecting the progress of cell differentiation. During tumor formation, IPK participates in regulating IP5 metabolism in the cell cycle, thereby promoting tumor cell proliferation and invasion.

The mechanism of action of IPK not only affects its role in physiological processes, but also makes it an important target for drug development and biomarker research. Many studies have shown that IPK is a target of many drugs, including anti-tumor drugs, antibiotics, and neurotransmitters. These drugs can exert their therapeutic effect by inhibiting the function of IPK, thus providing new ideas for tumor treatment and drug development.

IPK drug targets

Research on IPK as a drug target mainly focuses on the following aspects: first, the phosphorylation modification of IPK; second, the interaction between the function of IPK and its drug targets; third, the expression of IPK in different types of cells.

First, the researchers conducted an in-depth study on the phosphorylation modification of IPK. Many studies have shown that phosphorylation modification of IPK can affect the intracellular signaling process by regulating the phosphorylation of IP5. At the same time, phosphorylation modification of IPK can also induce the aggregation of IP5 to form IP5-IPK dimers, thereby activating the ATPase activity of IPK. These findings provide an important theoretical basis for drug target research on IPK.

Secondly, the researchers conducted in-depth studies on the interaction between IPK function and drug targets. Many studies have shown that IPK plays an important role in a variety of physiological processes, including cell proliferation, differentiation, and tumor formation. At the same time, IPK is also considered to be a target of many drugs, including anti-tumor drugs, antibiotics and neurotransmitters. These drugs can exert their therapeutic effect by inhibiting the function of IPK, thus providing new ideas for tumor treatment and drug development.

Finally, the researchers conducted in-depth studies on the expression of IPK in different types of cells. These findings indicate that IPK is expressed in a variety of cell types, including liver cells, kidney cells, and nerve cells. These findings provide an important experimental basis for the application of IPK in drug target research and drug development.

in conclusion

To sum up, IPK is a protein that plays an important role in cells, and it plays an important role in processes such as cell proliferation, differentiation, and tumor formation. The phosphorylation modification and functional interaction of IPK with drug targets provide an important theoretical basis for drug development and biomarker research. At the same time, IPK is expressed in various types of cells, providing an important experimental basis for drug target research and application in drug development. Therefore, IPK has broad application prospects as a drug target or biomarker.

Protein Name: Inositol-pentakisphosphate 2-kinase

Functions: Phosphorylates Ins(1,3,4,5,6)P5 at position 2 to form Ins(1,2,3,4,5,6)P6 (InsP6 or phytate). InsP6 is involved in many processes such as mRNA export, non-homologous end-joining, endocytosis, ion channel regulation. It also protects cells from TNF-alpha-induced apoptosis

The "IPPK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IPPK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets